Epithelial-mesenchymal transition and the invasive potential of tumors

Trends in Molecular Medicine

Volumn 14, Issue 5, 2008, Pages 199-209

  Gavert, Nancy ^a   Ben Ze'ev, Avri ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL ADHESION MOLECULE; FASCIN; IMMUNOGLOBULIN; PODOPLANIN; PROTEIN TYROSINE KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL FUNCTION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE CONTROL; HUMAN; MESENCHYME CELL; METASTASIS;

ANIMALS; DEVELOPMENTAL BIOLOGY; EPITHELIUM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESODERM; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 42749091317     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2008.03.004     Document Type: Article

References (99)

1. Lodish H., et al. Integrating cells into tissues. Molecular Cell Biology. 6th edn (2008), W.H. Feeman & Company 801-846
2. Evers B.M., et al. Small intestine. In: Schwartz S., et al. (Ed). Principles of Surgery. 7th edn (1999), McGraw-Hill 1217-1263
3. Sadler T.W. Prelaminar germ disc. Langman's Medical Embryology. 5th edn (1985), Williams and Wilkins 48-57
4. Hay E.D. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev. Dyn. 233 (2005) 706-720
5. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2 (2002) 442-454
6. Yang J., et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 (2004) 927-939
7. Tarin D., et al. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 65 (2005) 5996-6000
8. Gupta G.P., and Massagué J. Cancer metastasis: building a framework. Cell 127 (2006) 679-695
9. Trimboli A.J., et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res. 68 (2008) 937-945
10. Jemal A., et al. Cancer statistics, 2007. CA Cancer J. Clin. 57 (2007) 43-66
11. Brabletz T., et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and β-catenin. Cells Tissues Organs 179 (2005) 56-65
12. Brabletz T., et al. β-catenin and the morphogenesis of colorectal cancer. Virchows Arch. 441 (2002) 1-11
13. Gavert N., et al. L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J. Cell Biol. 168 (2005) 633-642
14. Rolandelli R., and Roslyn J.J. The colon and rectum. In: Sabiston D.C., and Lyerly K.H. (Eds). Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 15th edn (1997), W.B. Saunders Company 976
15. Thiery J.P., and Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7 (2006) 131-142
16. Peinado H., et al. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 48 (2004) 365-375
17. Gumbiner B.M. Regulation of cadherin-mediated adhesion in morphogenesis. Nat. Rev. Mol. Cell Biol. 6 (2005) 622-634
18. Ben-Ze'ev A., and Geiger B. Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer. Curr. Opin. Cell Biol. 10 (1998) 629-639
19. Yamada S., et al. Deconstructing the cadherin-catenin-actin complex. Cell 123 (2005) 889-901
20. Birchmeier W., and Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 1198 (1994) 11-26
21. Vleminckx K., et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66 (1991) 107-119
22. Perl A.K., et al. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392 (1998) 190-193
23. Derksen P.W., et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10 (2006) 437-449
24. Ceteci F., et al. Disruption of tumor cell adhesion promotes angiogenic switch and progression to micrometastasis in RAF-driven murine lung cancer. Cancer Cell 12 (2007) 145-159
25. Christiansen J.J., and Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 66 (2006) 8319-8326
26. Scheel C., et al. Adaptation versus selection: the origins of metastatic behavior. Cancer Res. 67 (2007) 11476-11479
27. Talmadge J.E. Clonal selection of metastasis within the life history of a tumor. Cancer Res. 67 (2007) 11471-11475
28. Peinado H., et al. Snail, ZEB and bHLH factors in tumor progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 7 (2007) 415-428
29. Cavallaro U., and Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4 (2004) 118-132
30. Conacci-Sorrell M., et al. The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Invest. 109 (2002) 987-991
31. Clevers H. Wnt/β-catenin signaling in development and disease. Cell 127 (2006) 469-480
32. Conacci-Sorrell M., et al. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of β-catenin signalling, Slug and MAPK. J. Cell Biol. 163 (2003) 847-857
33. Brabletz T., et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10356-10361
34. Jung A., et al. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear β-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am. J. Pathol. 159 (2001) 1613-1617
35. Barker N., and Clevers H. Tumor environment: a potent driving force in colorectal cancer?. Trends Mol. Med. 7 (2001) 535-537
36. Gavert N., and Ben-Ze'ev A. β-catenin signaling in biological control and cancer. J. Cell. Biochem. 102 (2007) 820-828
37. Takahashi K., and Suzuki K. Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion. Exp. Cell Res. 226 (1996) 214-222
38. Savagner P., et al. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell Biol. 137 (1997) 1403-1419
39. Yook J.I., et al. A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 8 (2006) 1398-1416
40. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
41. Duong T.D., and Erickson C.A. MMP-2 plays an essential role in producing epithelial-mesencymal transformation in the avian embryo. Dev. Dyn. 229 (2004) 42-53
42. Nawrocki-Raby B., et al. E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am. J. Pathol. 163 (2003) 653-661
43. Nawrocki-Raby B., et al. Upregulation of MMPs by soluble E-cadherin in human lung tumor cells. Int. J. Cancer 105 (2003) 790-795
44. Lu Z., et al. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion. Cancer Cell 4 (2003) 499-515
45. Kamiguchi H., and Lemmon V. IgCAMs: bidirectional signals underlying neurite growth. Curr. Opin. Cell Biol. 12 (2000) 598-605
46. Conacci-Sorrell M., et al. The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation. Cancer Res. 65 (2005) 11605-11612
47. Conacci-Sorrell M.E., et al. Nr-CAM is a target gene of the β-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Genes Dev. 16 (2002) 2058-2072
48. Gavert N., et al. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res. 67 (2007) 7703-7712
49. Williams E.J., et al. Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron 13 (1994) 583-594
50. Cavallaro U., et al. N-CAM modulates tumor-cell adhesion to matrix by inducing FGF-receptor signaling. Nat. Cell Biol. 3 (2001) 650-657
51. Christofori G. New signals from the invasive front. Nature 441 (2006) 444-450
52. Attisano L., and Wrana J. Signal transduction by the TGF-β superfamily. Science 296 (2002) 1646-1647
53. Nawshad A., et al. Transforming growth factor-β signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 179 (2005) 11-23
54. Zavadil J., and Böttinger E.P. TGF-β and epithelial-to-mesenchymal transitions. Oncogene 24 (2005) 5764-5774
55. Ahmed S., and Nawshad A. Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-β signaling. Cells Tissues Organs 185 (2007) 131-145
56. Liebner S., et al. β-Catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J. Cell Biol. 166 (2004) 359-367
57. Blobe G.C., et al. Role of transforming growth factor β in human disease. N. Engl. J. Med. 342 (2000) 1350-1358
58. Blobe G.C., and Elliott R. Role of transforming growth factor β in human cancer. J. Clin. Oncol. 23 (2005) 2078-2093
59. Dong M., et al. The type III TGF-β receptor suppresses breast cancer progression. J. Clin. Invest. 117 (2007) 206-217
60. Giannelli G., et al. Laminin-5 with transforming growth factor-β1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 129 (2005) 1375-1383
61. Hlubek F. Heterogeneous expression of Wnt/β-catenin target genes within colorectal cancer. Int. J. Cancer 121 (2007) 1941-1948
62. Giannelli G., et al. Transforming growth factor-β1 triggers hepatocellular carcinoma invasiveness via α3β1 integrin. Am. J. Pathol. 161 (2002) 183-193
63. Stoker M., et al. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327 (1987) 239-242
64. Birchmeier C., et al. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4 (2003) 915-925
65. Brembeck F.H., et al. Essential role of BCL9-2 in the switch between β-catenin's adhesive and transcriptional functions. Genes Dev. 18 (2004) 2225-2230
66. Brembeck F.H., et al. Balancing cell adhesion and Wnt signaling, the key role of β-catenin. Curr. Opin. Genet. Dev. 16 (2006) 51-59
67. Lee J.M., et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 172 (2006) 973-981
68. Karin M. Nuclear factor-κB in cancer development and progression. Nature 441 (2006) 431-436
69. Basseres D.S., and Baldwin A.S. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene 25 (2006) 6817-6830
70. Huber M.A., et al. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114 (2004) 569-581
71. Horikawa T., et al. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 67 (2007) 1970-1978
72. Julien S., et al. Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26 (2007) 7445-7456
73. Borghaei R.C., et al. NF-κB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem. Biophys. Res. Commun. 316 (2004) 182-188
74. Yan C., et al. A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-κB motif drives the transition from a repressed to an activated state of gene expression. FASEB J. 18 (2004) 540-541
75. Gilmore T.D., and Hershkovitz M. Inhibitors of NF-κB signaling: 785 and counting. Oncogene 25 (2006) 6887-6899
76. Cobleigh M.A., et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol. 17 (1999) 2639-2648
77. Small J.V., and Resch G.P. The comings and goings of actin: coupling protrusion and retraction in cell motility. Curr. Opin. Cell Biol. 17 (2005) 517-523
78. Condeelis J., and Segall J. Intravital imaging of cell movement in tumors. Nat. Rev. Cancer 3 (2003) 921-930
79. Vignjevic D., et al. Role of fascin in filopodial protrusion. J. Cell Biol. 174 (2006) 863-875
80. Hashimoto Y., et al. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker?. Int. J. Biochem. Cell Biol. 37 (2005) 1787-1804
81. Minn A.J., et al. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
82. Vignjevic D., et al. Fascin, a novel target of β-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res. 67 (2007) 6844-6853
83. Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 16 (2004) 14-23
84. Wicki A., et al. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9 (2006) 261-272
85. Wicki A., and Christofori G. The potential role of podoplanin in tumor invasion. Br. J. Cancer 96 (2007) 1-5
86. De Craene B., et al. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res. 65 (2005) 6237-6244
87. Valcourt U., et al. TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 16 (2005) 1987-2002
88. Zavadil J., et al. Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6686-6691
89. Waerner T., et al. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell 10 (2006) 227-239
90. Knogler K., et al. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis. Clin. Cancer Res. 13 (2007) 603-611
91. Fogel M., et al. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362 (2003) 869-875
92. Sarrio D., et al. Epithelial mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 68 (2008) 989-997
93. Aigner K., et al. The transcription factor ZEB1 (δEF1) represses plakophilin 3 during human cancer progression. FEBS Lett. 581 (2007) 1617-1624
94. Spaderna S., et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 131 (2006) 830-840
95. Spaderna S., et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res. 68 (2008) 537-544
96. Vesuna F., et al. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem. Biophys. Res. Commun. 367 (2008) 235-241
97. Jethwa P., et al. Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J. Gastroenterol. 14 (2008) 1044-1052
98. Yang M.-H., et al. Direct regulation of TWIST by HIF-1a promotes metastasis. Nat. Cell Biol (2008). http://www.nature.com/ncb/index.html 10.1038/ncb1691 http://www.nature.com/ncb/index.html
99. Hipps S., et al. Precise measurement of the E-cadherin repressor Snail in formalin-fixed endometrial carcinoma using protein lysate microarrays. Clin. Exp. Metast. (2008). http://www.springerlink.com/content/100126/ 10.1007/s10585-008-9149-3 http://www.springerlink.com/content/100126/